pharma · Pain · Hyponatremia · CPIX
Cumberland Pharmaceuticals
CUMBERLAND PHARMACEUTICALS INC
Cumberland Pharmaceuticals clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1600 W End Ave, #1300, Nashville, Tennessee 37203, US
- Founded
- 1999
- Employees
- 128
- Programs
- 53
- Drugs
- 26
- Patents
- 34
Cumberland Pharmaceuticals projects
6 ClinicalTrials.gov programs sponsored by Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Acetadote
CUMBERLAND PHARMACEUTICALS INC
Glioblastoma
1 trial -
IVIb
CUMBERLAND PHARMACEUTICALS INC
Healthy
1 trial -
Kristalose
CUMBERLAND PHARMACEUTICALS INC
Bowel Evacuant Prior to Colonoscopy
1 trial -
conivaptan hydrochloride
CUMBERLAND PHARMACEUTICALS INC
Kidney Diseases
1 trial -
conivaptan hydrochloride
CUMBERLAND PHARMACEUTICALS INC
Liver Disease
2 trials -
telavancin
CUMBERLAND PHARMACEUTICALS INC
Kidney Diseases
1 trial
Frequently asked questions
How many clinical projects does Cumberland Pharmaceuticals have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.